| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/07/2010 | US7790950 Use of phytoene synthase for controlling transgene escape |
| 09/07/2010 | US7790877 Modulation transcription, translation of nucleic acid by oligonucleotide binding; increase antibody efficiency |
| 09/07/2010 | US7790874 Polynucleotides that decrease the effects of neighboring sequences or genes also called genetic insulator elements; transformed plant cell and transgenic plants; insect resistance |
| 09/07/2010 | US7790873 Expression cassettes for seed-preferential expression in plants |
| 09/07/2010 | US7790872 Rice catalase B promoter |
| 09/07/2010 | US7790871 Anti-TNFα antibodies and methods of use |
| 09/07/2010 | US7790870 nucleic acid molecule encoding a fusion protein comprising four linked polypeptides; suitable for use in gene therapeutical treatment of patients infected with HIV |
| 09/07/2010 | US7790869 Massive parallel method for decoding DNA and RNA |
| 09/07/2010 | US7790868 Teal fluorescent proteins (mTFP1) |
| 09/07/2010 | US7790867 Vaccinia virus-related nucleic acids and microRNA |
| 09/07/2010 | US7790866 a novel DNA, a carcinoma-associated gene comprising the DNA, a recombinant protein encoded by the DNA, an antibody binding to the protein, an anti-carcinoma agent comprising the antibody, a low-molecular-weight compound binding to the protein, a screening system |
| 09/07/2010 | US7790858 Immunoadhesin comprising increased neonatal Fc receptor specificity for use in treatment and prevention of cell proliferative disorders |
| 09/07/2010 | US7790854 antibody zeta -C2 raised against the sequence set forth in SEQ ID NO:2, which specifically binds to the atypical isoform protein kinase M zeta (PKM zeta ); Alzheimer's disease (AD) and neuroblastoma; using aPKC in diagnosis, drug screening and gene therapy |
| 09/07/2010 | US7790851 heterodimeric receptor complex comprising an isolated soluble cytokine receptor and a soluble zcytor11 polypeptide; for use in treatment of cell proliferative, inflammatory and immune disorders |
| 09/07/2010 | US7790850 comprising a fusion protein comprising a first portion of a GPCR, where the first portion comprises the TM1, TM2, TM3, TM4 and TM5 regions of the GPCR, a stable folded protein insertion and a second portion of the GPCR, where the second portion comprises the TM6 and TM7 regions |
| 09/07/2010 | US7790849 Enhancement of retroviral gene transduction employing polypeptides comprising the fibronectin heparin II binding domain |
| 09/07/2010 | US7790848 g-protein coupled receptors for identifying modulators of taste enhancement; food processing and drug design; for screening tastants |
| 09/07/2010 | US7790847 orthogonal pairs of tRNAs and aminoacyl-tRNA synthetases that can incorporate the unnatural amino acid phenylselenocysteine into proteins produced in eubacterial host cells (E. coli) |
| 09/07/2010 | US7790846 Bacillus thuringiensis Cry9 toxins |
| 09/07/2010 | US7790845 Bacillus voltage-sensitive ion-selective transport protein for use in dientifying antagonist/agonist for prevention and treatment of cardiovascular disorders |
| 09/07/2010 | US7790843 Cypin polypeptide and fragments thereof |
| 09/07/2010 | US7790696 Cationic liposomes containing immune response generating moieties |
| 09/07/2010 | US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 09/07/2010 | US7790691 A first oligonucletide and a second are complimentary and hybridize with each other to a target nucleic acid for their use in modulating gene expression; hybridize to a portion of a target RNA resulting in loss of normal function of the target RNA |
| 09/07/2010 | US7790690 Glucose sensitive regulator of insulin transcription |
| 09/07/2010 | US7790684 Method of inhibiting osteoclast activity |
| 09/07/2010 | US7790682 Use in tissue engineering, tissue repair; stimulating mitogenesis in cells |
| 09/07/2010 | US7790676 Soluble IL-17RA/RC fusion proteins |
| 09/07/2010 | US7790674 Treating inflammatory disease; use in combination with other antiinflammatory agents such as anakinra; rheumatoid arthritis for example; Ang-2 inhibitor peptides of amino acid sequence WDPWT |
| 09/07/2010 | US7790655 A system for whole antibody cell surface display on mammalian cells to facilitate the rapid identification of antibodies with modified Fc regions having altered effector function |
| 09/07/2010 | US7790460 Using modified light condition, nutrient broths and solid matrices to stimulate embryogenesis, embryo germination and propagate transgenic cotton |
| 09/07/2010 | US7790459 In vitro maturation of immature human oocytes |
| 09/07/2010 | US7790452 Non-infectious chimeras that include the nucleic acid signature of most bacterial and viral biological threat agents; for use in nucleic acid-based biodetectors and diagnostic products for biodefense |
| 09/07/2010 | US7790451 Herpes simplex virus directed specifically to kill tumor cells; antitumor agents |
| 09/07/2010 | US7790450 Plasmid comprising heat shock promoter 16 for production of heterologous proteins in Schizosaccharomyces pombe; multicloning vector |
| 09/07/2010 | US7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor |
| 09/07/2010 | US7790448 Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene |
| 09/07/2010 | US7790447 Vector expressing n-deacetylase/n-sulfotransferase 2 |
| 09/07/2010 | US7790446 Plasmid comprising bovine papillomavirus type 1 E2 protein-dependent minichromosome maintenance element (MME) comprised of E2 multimeric binding sites can provide stable maintenance replication function to the mouse polyomavirus (PyV) core origin plasmids |
| 09/07/2010 | US7790445 Polypeptide having an improved cytosine deaminase activity |
| 09/07/2010 | US7790432 Alanine 2,3-aminomutases and related polynucleotides |
| 09/07/2010 | US7790431 Methods and materials for the production of shikimic acid |
| 09/07/2010 | US7790430 Cellulase resistant to surfactants |
| 09/07/2010 | US7790428 Essential fungal polypeptide, CaYDR341c, and methods of use thereof |
| 09/07/2010 | US7790426 Sesquiterpene synthases and methods of use |
| 09/07/2010 | US7790425 Using transgenic trichoderma as bioreactor for production of monoglucuronide degrading enzyme for use in treatment of systemic lupus erythematosus, autoimmune diseases or thrombosis |
| 09/07/2010 | US7790421 Affixing puromycin to ribonucleic acid sequence via covalent modification/ligation; for the isolation of proteins or nucleic acids with desired properties from large pools |
| 09/07/2010 | US7790420 Screening for expression of soluble protein via modification of peptide substrates; novel reporter molecules |
| 09/07/2010 | US7790419 Antiviral vectors |
| 09/07/2010 | US7790418 Isothermal amplification of nucleic acids on a solid support |
| 09/07/2010 | US7790413 Capable synthesising mono-, bi- and/or tri-cyclic sesquiterpenes having a C2-C7 or a C3-C7 bond, via farnesyl-pyrophosphate precursor; for catalyzing cyclisation to the santalene and bergamotene carbon skeletons |
| 09/07/2010 | US7790411 Everninomicin biosynthetic genes |
| 09/07/2010 | US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 09/07/2010 | US7790403 Methods for predicting preganancy outcome in a subject by hCG assay |
| 09/07/2010 | US7790389 Antireflective coatings for high-resolution photolithographic synthesis of DNA arrays |
| 09/07/2010 | US7790388 Generating circularized nucleic acid via fragmenting target sequences, incubating with single stranded circularizing adaptor, recovering circular DNA |
| 09/07/2010 | US7790385 Kits containing oligonucleotide nucleic acid that hybridizes target, with tail containing detecatble reporter and purine or pyrimidine endonuclease cleavage site attached through photodiester bonds |
| 09/07/2010 | US7790381 Method for creating polynucleotide and polypeptide sequences |
| 09/07/2010 | US7790377 Identification of safe, natural compounds that interfere with survival and development; testing action on famesoid X activated receptor (FXR) and/or ecdysone receptor (EcR) mediated transcription |
| 09/07/2010 | US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample |
| 09/07/2010 | US7790374 creating collection of single-stranded fragments of master sequence, all having same 5'-terminus and deletion in 3'-terminus, elongating via polymerase, hybridizing; plasmids |
| 09/07/2010 | US7790372 Using allelic profile of human insulin receptor substrate 2 gene as evaluative tool in prediciting vesnarinone induced reduction in blood granulocytes |
| 09/07/2010 | US7790369 Method for producing polymers |
| 09/07/2010 | US7790366 NANBV diagnostics and vaccines |
| 09/07/2010 | US7790187 Recombinant granule antigen protein (GRA6) for use in diagnosis, prevention and treatment of parasitic infection |
| 09/07/2010 | US7790185 Bacterial mutant for generating bacterial toxins for use in developing vaccine against infections; cultivating Bordetella pertussis bacteria that lack cysteine desulfinase activity by knocking out Bordetella pertussis cysteine desulfinase gene, whereby an enhanced amount of PT is produced |
| 09/07/2010 | US7790181 Vaccine preparations comprise full-length cDNA copies of the EEE genome which has been altered such that the RNA produced from the cDNA, and the virus produced there from is attenuated and useful as a live vaccine for human and veterinary use |
| 09/07/2010 | US7790180 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 09/07/2010 | US7790179 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 09/07/2010 | US7790174 G-CSF polypeptides and uses thereof |
| 09/07/2010 | US7790170 Transgenic plant comprising expression vector coding mannheimia modified toxin protein for use in preparing vaccine against respiratory infection in domestic animals; veterinary medicine |
| 09/07/2010 | US7790168 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 09/07/2010 | US7790166 Anti-CD40 antibodies capable of blocking B-cell activation |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790157 Methods of modulating CARK protein activity |
| 09/07/2010 | US7790155 Calbindin-D28K protection against glucocorticoid induced cell death |
| 09/07/2010 | US7790154 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 09/07/2010 | CA2608864C Recombinant mva virus, and the use thereof |
| 09/07/2010 | CA2596274C Recombinant mva virus, and the use thereof |
| 09/07/2010 | CA2507664C Novel neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product |
| 09/07/2010 | CA2450871C Assay for identifying inhibitors of hiv rt dimerization |
| 09/07/2010 | CA2412609C Methods for isolating centromere dna |
| 09/07/2010 | CA2348415C Method for gold deposition |
| 09/07/2010 | CA2333253C Molecular torches |
| 09/07/2010 | CA2259156C Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 09/07/2010 | CA2231774C Plants which synthesize a modified starch, process for the production thereof and modified starch |
| 09/05/2010 | CA2679784A1 Diagnostic, prognostic and treatment methods |
| 09/04/2010 | CA2658351A1 Method for targeted cell ablation |
| 09/02/2010 | WO2010099536A2 Engineered proteins with high affinity for dota chelates |
| 09/02/2010 | WO2010099501A2 Transaminase biocatalysts |
| 09/02/2010 | WO2010099500A2 Beta-glucosidase variant enzymes and related polynucleotides |
| 09/02/2010 | WO2010099489A2 Ovarian cancer methylome |
| 09/02/2010 | WO2010099477A2 Polypeptide structural motifs associated with cell signaling activity |
| 09/02/2010 | WO2010099472A2 Spanx-b polypeptides and their use |
| 09/02/2010 | WO2010099432A2 Recognition of cyp2e1 epitopes |
| 09/02/2010 | WO2010099384A1 HYPER IgE ANIMAL MODEL WITH ENHANCED IMMUNOGLOBULIN HEAVY CHAIN CLASS SWITCHING TO Cε |
| 09/02/2010 | WO2010099383A2 Compositions and methods for ex vivo hepatic nucleic acid delivery |
| 09/02/2010 | WO2010099365A2 Pesticidal proteins and methods for their use |
| 09/02/2010 | WO2010099341A1 Compositions and methods for inhibiting expression of mig-12 gene |
| 09/02/2010 | WO2010099320A1 Plant resistance to banana bunchy top virus |